Trial reportGeneral hospital psychiatry
Bipolar disorder measurement-based care: Two-phase trial in primary care.
Trial report in General hospital psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo assess feasibility and preliminary effectiveness of measurement-based care (MBC) for bipolar disorder.
methodsWe recruited adults with bipolar disorder in community primary care clinics with integrated mental health services. We used the Patient Mania Questionnaire-9 (PMQ-9, manic symptoms) and Patient Health Questionnaire-9 (PHQ-9, depressive symptoms) for MBC. In the lead-in phase, a fidelity score assessed adherence to MBC. In the randomization phase, patients were randomized to 6 months of MBC or usual care. The primary outcome was number of treatment changes. Baseline and 6-month participant surveys assessed other outcomes. We used a Mann-Whitney U test and descriptive statistics.
resultsIn the lead-in phase, five psychiatrists and fifteen patients participated, with symptom measures completed at all participant visits (n = 40 visits). In the randomization phase, all invited psychiatrists (n = 6) and psychiatric advanced practice registered nurses (n = 3) participated. Thirty patients were consented and randomized. There was no statistically significant difference in the number of treatment changes between groups (Med
conclusionGiven the feasibility and preliminary effectiveness of MBC for bipolar disorder in primary care, a larger fully powered trial should test if MBC yields greater reduction in symptoms and increased quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.